LandOfFree - US Patents - Listing for Drug, bio-affecting and body treating compositions,Designated organic active ingredient containing,Peptide containing doai

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-Met receptor regulation by angiotensin IV (AT 4 )...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal amide cyclic renin inhibitors containing peptide isos

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminal modified oxamyl dipeptides as inhibitors of the...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C-terminus modified heptapeptide LHRH analogs

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C.sup.63 -amide derivatives of 34-de(acetylglucosaminyl)-34-deox

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C1 inhibitor muteins and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C5a receptor antagonists

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C5A receptor antagonists having substantially no agonist activit

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

C9 complement inhibitor

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

CA IX-specific inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Caip-like gene family

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Calcineurin interacting protein compositions and methods

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Calcitonin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Calcitonin derivatives

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Calcitonin drug-oligomer conjugates, and uses thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Calcitonin gene-related peptides for treating erectile dysfuncti